Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Stellar Biotechnologies, Inc. (SBOTF) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Stellar Biotechnologies manufactures Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. Potent, yet proven safe in humans, KLH operates as both a vital component for conjugate vaccines (targeting cancer, autoimmune and infectious diseases) as well as an antigen for measuring immune status. The company has established practices, facilities and proprietary capabilities to address the demand for renewable, commercial-scale supplies of high-quality, GMP-grade KLH. For more information visit the company’s Web site at www.stellarbiotechnologies.com

Let us hear your thoughts below:

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *